Literature DB >> 23162111

Need for rigor in design, reporting, and interpretation of transcriptomic biomarker studies.

N D Walter1, L Bemis, M Edwards, A R Ovrutsky, E D Chan.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23162111      PMCID： PMC3502969          DOI： 10.1128/JCM.06775-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  11 in total

Review 1.  Fundamentals of experimental design for cDNA microarrays.

Authors:  Gary A Churchill
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

2.  MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Authors:  Nicholas J Hand; Amber M Horner; Zankhana R Master; LaTasha A Boateng; Claire LeGuen; Marina Uvaydova; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

3.  Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

Authors:  Long-Gang Wang; Jin Gu
Journal:  Cancer Epidemiol       Date:  2011-10-21       Impact factor: 2.984

4.  CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Authors:  Payam Nahid; Jussi Saukkonen; William R Mac Kenzie; John L Johnson; Patrick P J Phillips; Janet Andersen; Erin Bliven-Sizemore; John T Belisle; W Henry Boom; Annie Luetkemeyer; Thomas B Campbell; Kathleen D Eisenach; Richard Hafner; Jeffrey L Lennox; Mamodikoe Makhene; Susan Swindells; M Elsa Villarino; Marc Weiner; Constance Benson; William Burman
Journal:  Am J Respir Crit Care Med       Date:  2011-10-15       Impact factor: 21.405

5.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

6.  Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.

Authors:  Joana Heinzelmann; Brenda Henning; Jimsgene Sanjmyatav; Nicole Posorski; Thomas Steiner; Heiko Wunderlich; Mieczyslaw R Gajda; Kerstin Junker
Journal:  World J Urol       Date:  2011-01-13       Impact factor: 4.226

7.  Circulating microRNAs in patients with active pulmonary tuberculosis.

Authors:  Yurong Fu; Zhengjun Yi; Xiaoyan Wu; Jianhua Li; Fuliang Xu
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

8.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

10.  Next-generation sequencing of microRNAs for breast cancer detection.

Authors:  Qian Wu; Zuhong Lu; Hailing Li; Jiafeng Lu; Li Guo; Qinyu Ge
Journal:  J Biomed Biotechnol       Date:  2011-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.